Zobrazeno 1 - 10
of 52
pro vyhledávání: '"G. Durm"'
Publikováno v:
Rep Pract Oncol Radiother
Introduction Pulmonary large-cell neuroendocrine carcinoma (LCNEC) is a very rare disease, comprising approximately 3% of lung cancers. Even for Stage I disease, recurrence after resection is common, with a poor five-year overall survival. We present
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Regular and young investigator award abstracts.
Background Checkpoint inhibitors are a promising therapy for patients with solid tumors; however, many patients require additional therapies to maximize clinical benefit or overcome resistance.1 The type-1 cytokine interleukin-21 (IL-21) is a promisi
Autor:
H. Henary, John C. Krauss, Timothy J. Price, Geoffrey I. Shapiro, Marwan Fakih, Timothy F. Burns, Jayesh Desai, Crystal S. Denlinger, John H. Strickler, Keunchil Park, Brett E. Houk, Funda Meric-Bernstam, Ramaswamy Govindan, J. Russell Lipford, Fabrice Barlesi, Andrew L. Coveler, James Kuo, Gregory Friberg, Adrian G. Sacher, Tae Won Kim, Pamela N. Munster, Gataree Ngarmchamnanrith, J. Kim, Jude Canon, David S. Hong, Gerald S. Falchook, Piro Lito, Yung-Jue Bang, Bob T. Li, Yasutoshi Kuboki, J. Ngang, G. Durm, Grace K. Dy, Suresh S. Ramalingam
Publikováno v:
N Engl J Med
BACKGROUND: No therapies for targeting KRAS mutations in cancer have been approved. The KRAS p.G12C mutation occurs in 13% of non–small-cell lung cancers (NSCLCs) and in 1 to 3% of colorectal cancers and other cancers. Sotorasib is a small molecule
Autor:
Thomas J. Birdas, G. Durm, Kenneth A. Kesler, H. Liu, DuyKhanh P. Ceppa, Shadia I. Jalal, Nasser H. Hanna, Karen M. Rieger
Publikováno v:
Journal of Thoracic Oncology. 16:S257-S258
Autor:
Kenneth A. Kesler, G. Durm, Shadia I. Jalal, Thomas J. Birdas, DuyKhanh P. Ceppa, Lawrence H. Einhorn, Nasser H. Hanna, Melissa Yan, Karen M. Rieger
Publikováno v:
Journal of Thoracic Oncology. 16:S187-S188
Autor:
Gataree Ngarmchamnanrith, David S. Hong, Grace K. Dy, Timothy F. Burns, Ramaswamy Govindan, G. Durm, K. Park, J. Kim, Fabrice Barlesi, Agnes Ang, Bob T. Li, John H. Strickler, Abraham Anderson, J.R. Lipford, Y-J. Bang, Gerald Steven Falchook
Publikováno v:
Journal of Thoracic Oncology. 16:S28-S29
Autor:
Abraham Anderson, Gerald Steven Falchook, Ramaswamy Govindan, Timothy F. Burns, Agnes Ang, Bob T. Li, J. Kim, Grace K. Dy, Y-J. Bang, K.C. Park, Gataree Ngarmchamnanrith, David S. Hong, Fabrice Barlesi, John H. Strickler, R. Lipford, G. Durm
Publikováno v:
Revue des Maladies Respiratoires Actualités. 13:121-122
Introduction L’etude de phase 1 du sotorasib, inhibiteur de KRASG12C, a demontre un profil de tolerance favorable et une activite antitumorale chez les pts atteints de CPNPC, KRASG12C mute, avec un taux de reponse objective (TRO) de 54 % sur 13 pts
Autor:
J.H. Strickler, M. Fakih, T.J. Price, J. Desai, G. Durm, J.C. Krauss, Y. Kuboki, T.W. Kim, A. Sacher, H. Henary, J. Kim, D.S. Hong
Publikováno v:
Annals of Oncology. 31:S1274-S1275
Autor:
D.S. Hong, Y-J. Bang, F. Barlesi, G. Durm, G.S. Falchook, R. Govindan, G.K. Dy, K. Park, J.H. Strickler, T.F. Burns, J. Kim, A. Ang, J.R. Lipford, G. Ngarmchamnanrith, A. Anderson, B.T. Li
Publikováno v:
Annals of Oncology. 31:S1389-S1390